Trump-Linked Firm Secures $40 Million Federal Biosecurity Contracts
A company tied to the president's sons received major contracts for disease screening.
1Federal Contracts Awarded
The Trump administration awarded nearly $40 million in federal contracts to XpresTest, a biosecurity firm. These funds were designated for screening Ebola at U.S. airports and responding to disease outbreaks in the Democratic Republic of Congo. This total value is seven times higher than all previous government contracts the company had received.
2Investment Ties Revealed
The contracts were granted shortly after American Ventures, a fund linked to Donald Trump Jr. and Eric Trump, invested in XpresTest’s parent company, XWELL. The Trump sons hold a stake of more than 10% in Dominari Holdings, the financial firm that launched the investment fund and operates from within Trump Tower.
3Company Background and Experience
XWELL is primarily known for operating airport spas that offer massages, manicures, and chakra beds. While XpresTest has experience monitoring for COVID-19 at U.S. airports, it lacks any prior experience in international biosecurity or working in volatile regions like the Democratic Republic of Congo, where Ebola outbreaks have recently proven fatal.
4Operational Risks and Uncertainty
Ezra Ernst, CEO of XWELL, admitted that international work is new for the company and expressed uncertainty regarding their ability to execute the contract in the Congo. He acknowledged the project is risky and noted that none of the awarded contract funds are guaranteed, depending on shifting administration priorities and operational success.
5Shift in Global Strategy
The contracts align with the State Department’s America First Global Health Strategy, which prioritizes using foreign aid to promote American companies. This approach marks a departure from previous administrations that typically partnered with the World Health Organization and established global health agencies to manage international disease outbreaks and public health responses.
6Defense of Investment Status
A spokesperson for Donald Trump Jr. and Eric Trump stated they are passive, minority investors with no involvement in contract negotiations. Anthony Hayes, CEO of Dominari Holdings, also denied any influence, claiming they have never heard of the Trump sons using their family name to secure government deals for their portfolio companies.
7Financial Implications of Sale
XWELL recently announced plans to sell XpresTest and its spa business for $13 million. Because the government contracts will follow the subsidiary, XWELL stands to benefit financially from the deal despite not performing the actual work. The company previously stated this sale supports a new strategic direction in the national security sector.
8Pattern of Financial Enrichment
This development follows other reports of companies linked to the Trump family receiving significant federal support. Previously, a drone company and a critical minerals group received government contracts or support after the Trump sons acquired stakes. The president himself has also seen his cryptocurrency ventures grow in value during his second term.
9Congressional Oversight Expected
The financial ties between the Trump family and government-funded entities are expected to become a primary focus for Congress. Democrats, having gained control of the House and Senate, have signaled intent to investigate potential corruption and the misuse of taxpayer dollars, citing concerns that public interest is being compromised for private gain.
Original article: ProPublica — Trump-Linked Firm Secures $40 Million Federal Biosecurity Contracts